Karlien Coene News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Karlien coene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Karlien Coene Today - Breaking & Trending Today

Newborn screening for epilepsy in sight through the discovery of novel disease biomarkers


 E-Mail
The door has finally opened on screening newborn babies for pyridoxine-dependent epilepsy (PDE), a severe inherited metabolic disorder. This screening promises to enable better and earlier treatment of the disease. To identify new biomarkers that can be used in the newborn screening protocol, also known as the neonatal heel prick, researchers at the Radboud University Medical Center joined forces with scientists at the Radboud University s FELIX laser laboratory. They published their findings in The
Journal of Clinical Investigation.
The discovery and identification of the new biomarkers could lead to an important addition to worldwide newborn screening protocols. Currently, there are over a thousand known inborn metabolic diseases (IMD), but only 2% of them can be detected through the neonatal heel prick. While these are relatively rare as individual disorders, in the Netherlands, every other day a child is born with an IMD. These disorders have severe healt ....

Karlien Coene , Jonathan Martens , Radboud University Medical Center , Radboud University , Translational Metabolic Laboratory , Radboud University Medical , ஜொனாதன் மார்டென்ஸ் ,

Biomarker discovery can open door to screening newborn babies for pyridoxine-dependent epilepsy


Biomarker discovery can open door to screening newborn babies for pyridoxine-dependent epilepsy
The door has finally opened on screening newborn babies for pyridoxine-dependent epilepsy (PDE), a severe inherited metabolic disorder. This screening promises to enable better and earlier treatment of the disease.
To identify new biomarkers that can be used in the newborn screening protocol, also known as the neonatal heel prick, researchers at the Radboud University Medical Center joined forces with scientists at the Radboud University s FELIX laser laboratory. They published their findings in The
Journal of Clinical Investigation.
The discovery and identification of the new biomarkers could lead to an important addition to worldwide newborn screening protocols. Currently, there are over a thousand known inborn metabolic diseases (IMD), but only 2% of them can be detected through the neonatal heel prick. ....

Karlien Coene , Jonathan Martens , Emily Henderson , Radboud University Nijmegen , Radboud University Medical Center , Laboratory Specialist , Radboud University , Translational Metabolic Laboratory , ஜொனாதன் மார்டென்ஸ் , எமிலி ஹென்டர்சன் , ஆய்வகம் நிபுணர் ,